One thing we know for sure, is that they are talking to big Pharma and yes, it takes a long time to work out. They've been trying to build value by exploring multiple uses, as each use has a price. A buyout will happen, but more likely a joint venture to replenish cash. And on we go.
Market Data 
Markets 
AI
